These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 11243407)
1. The role of NF-kappaB in the regulation of the expression of wilms tumor suppressor gene WT1. Chen Y; Williams BR Gene Expr; 2000; 9(3):103-14. PubMed ID: 11243407 [TBL] [Abstract][Full Text] [Related]
2. Activation of the wt1 Wilms' tumor suppressor gene by NF-kappaB. Dehbi M; Hiscott J; Pelletier J Oncogene; 1998 Apr; 16(16):2033-9. PubMed ID: 9572484 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter. Fraizer GC; Wu YJ; Hewitt SM; Maity T; Ton CC; Huff V; Saunders GF J Biol Chem; 1994 Mar; 269(12):8892-900. PubMed ID: 8132626 [TBL] [Abstract][Full Text] [Related]
4. PAX 8 regulates human WT1 transcription through a novel DNA binding site. Fraizer GC; Shimamura R; Zhang X; Saunders GF J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203 [TBL] [Abstract][Full Text] [Related]
5. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor. Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter. Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865 [TBL] [Abstract][Full Text] [Related]
7. A far upstream cis-element is required for Wilms' tumor-1 (WT1) gene expression in renal cell culture. Scholz H; Bossone SA; Cohen HT; Akella U; Strauss WM; Sukhatme VP J Biol Chem; 1997 Dec; 272(52):32836-46. PubMed ID: 9407061 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
9. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter. McCoy C; McGee SB; Cornwell MM Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899 [TBL] [Abstract][Full Text] [Related]
10. Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2. McConnell MJ; Cunliffe HE; Chua LJ; Ward TA; Eccles MR Oncogene; 1997 Jun; 14(22):2689-700. PubMed ID: 9178767 [TBL] [Abstract][Full Text] [Related]
11. Identification of connective tissue growth factor as a target of WT1 transcriptional regulation. Stanhope-Baker P; Williams BR J Biol Chem; 2000 Dec; 275(49):38139-50. PubMed ID: 10973960 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Hewitt SM; Hamada S; McDonnell TJ; Rauscher FJ; Saunders GF Cancer Res; 1995 Nov; 55(22):5386-9. PubMed ID: 7585606 [TBL] [Abstract][Full Text] [Related]
13. The role of Wilms' tumor genes. Hirose M J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307 [TBL] [Abstract][Full Text] [Related]
14. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Dehbi M; Ghahremani M; Lechner M; Dressler G; Pelletier J Oncogene; 1996 Aug; 13(3):447-53. PubMed ID: 8760285 [TBL] [Abstract][Full Text] [Related]
15. Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1. Goodyer P; Dehbi M; Torban E; Bruening W; Pelletier J Oncogene; 1995 Mar; 10(6):1125-9. PubMed ID: 7700638 [TBL] [Abstract][Full Text] [Related]
16. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Werner H; Shen-Orr Z; Rauscher FJ; Morris JF; Roberts CT; LeRoith D Mol Cell Biol; 1995 Jul; 15(7):3516-22. PubMed ID: 7791758 [TBL] [Abstract][Full Text] [Related]
18. WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Haber DA; Park S; Maheswaran S; Englert C; Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ Science; 1993 Dec; 262(5142):2057-9. PubMed ID: 8266105 [TBL] [Abstract][Full Text] [Related]
19. Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1. Moshier JA; Skunca M; Wu W; Boppana SM; Rauscher FJ; Dosescu J Nucleic Acids Res; 1996 Mar; 24(6):1149-57. PubMed ID: 8604351 [TBL] [Abstract][Full Text] [Related]
20. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]